BRCA1 and posterior cortical atrophy: Therefore, we included AA PCa patients into this study who were recruited either within the Department of Defense (DOD) Health Care System [9] or the National Cancer Institute (NCI) Maryland Case-Control Study [10], allowing for an evaluation of BRCA1/2 mutation frequencies in AA and CA men with PCa.